MIRM
Mirum Pharmaceuticals Inc
82.90$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 | 1.49 | 1.48 | 1.65 | 1.89 | 2.06 | 2.28 | 2.57 | 2.33 | 2.97 | 2.72 | 2.78 | 9.75 | |
| 0.25 | 0.54 | 0.38 | 0.43 | 0.44 | 0.47 | 0.47 | 0.47 | 0.45 | 0.56 | 0.49 | 0.48 | 1.78 | |
| 0.91 | 0.95 | 1.10 | 1.22 | 1.46 | 1.59 | 1.81 | 2.10 | 1.89 | 2.40 | 2.23 | 2.30 | 7.97 | |
| 0.64 | 0.66 | 0.69 | 0.69 | 0.66 | 0.91 | 0.94 | 0.93 | 0.75 | 1.02 | 1.66 | 1.43 | 4.46 | |
| 0.89 | 0.85 | 0.97 | 0.87 | 1.06 | 0.94 | 1.18 | 1.27 | 1.09 | 1.48 | 1.64 | 1.29 | 4.95 | |
| 1.52 | 1.65 | 1.66 | 1.73 | 1.72 | 2.09 | 2.12 | 2.20 | 1.84 | 2.49 | 3.30 | 2.97 | 9.67 | |
| -0.61 | -0.70 | -0.56 | -0.51 | -0.27 | -0.50 | -0.31 | -0.10 | 0.05 | -0.09 | -1.07 | -0.67 | -1.70 | |
| 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.06 | 0.04 | 0.21 | |
| -0.57 | -0.76 | -0.53 | -0.51 | -0.29 | -0.50 | -0.28 | -0.11 | 0.05 | -0.10 | -13.42 | -1.03 | -13.53 | |
| 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | -0.01 | 0.02 | 0.01 | 0.00 | 0.02 | 0.01 | 0.03 | 0.04 | |
| -0.57 | -0.76 | -0.54 | -0.52 | -0.30 | -0.49 | -0.30 | -0.12 | 0.05 | -0.11 | -13.43 | -1.06 | -13.57 | |
| -0.42 | -0.56 | -0.33 | -0.31 | -0.09 | -0.30 | -0.08 | 0.08 | 0.16 | 0.09 | -13.24 | -0.18 | -12.26 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.